8. CPC’S IMPACT MATHEMATICA POLICY RESEARCH
Table 8.10. Aggregate CPC-wide results, by year and cumulative
Outcome
Total
Medicare
expenditures
without fees Hospitalizations
Outpatient ED
visits
Primary care
visits in all
settings
Office-based
primary care
visits
30-day
readmissions
Year 1
Estimate
-$68,569,900
a
-1,862
a
-797 -27,867 -11,567 -480
90% CI LL -$111,373,479 -3,484 -3,271 -55,816 -28,099 -976
90% CI UL -$25,766,320 -239 1,677 81 4,965 16
Year 2
Estimate -$49,190,714 -1,950 -1,509
-39,027
a
-27,770
a
-90
90% CI LL -$100,511,538 -4,046 -4,625 -75,626 -50,364 -589
90% CI UL $2,130,110 146 1,606 -2,429 -5,177 409
Year 3
Estimate -$19,720,803 -1,229
-5,962
a
-34,500
-35,227
a
-67
90% CI LL -$81,305,937 -3,547 -9,578 -81,927 -64,802 -645
90% CI UL $41,864,332 1,089 -2,346 12,926 -5,652 512
Year 4
Estimate -$14,870,706 -3,109
-7,204
a
-35,771 -33,221 -299
90% CI LL -$107,360,416 -6,292 -12,337 -107,732 -79,198 -1,007
90% CI UL $77,619,003 73 -2,071 36,190 12,757 409
Years 1–4
combined
Estimate -$152,352,128
-8,150
a
-15,472
a
-137,166
-107,785
a
-936
90% CI LL -$360,895,871 -15,789 -27,333 -296,978 -208,920 -2,799
90% CI UL $56,191,615 -510 -3,610 22,645 -6,650 927
Source: Analysis of Medicare claims data for October 2011 through December 2016.
Notes: This table calculates the estimated effects over all CPC regions and attributed Medicare FFS beneficiaries who were in
the intent-to-treat analysis sample for Years 1, 2, 3, and 4 of CPC. The total number of beneficiaries attributed to CPC
practices in the annual analysis sample was 365,996 in Year 1, 409,750 in Year 2, 442,160 in Year 3, and 482,287 in
Year 4. The number of eligible beneficiary months for the same number of beneficiaries in CPC practices was 3,908,795
in Year 1, 4,451,025 in Year 2, 4,837,588 in Year 3, and 6,505,371 in Year 4.The number of eligible index discharges (for
readmissions) was 89,847 in Year 1, 96,696 in Year 2, 108,173 in Year 3, and 141,233 in Year 4. For calculating the
cumulative aggregate impacts (across Years 1, 2, 3, and 4 combined), we added the yearly aggregate impacts over the
four years. Impact estimates are from difference-in-differences regressions using both patient- and practice-level control
variables from the pre-CPC period. See Section 8.2 for a full list of measures and definitions, as well as a discussion of
methods. Green shading with bolded text signifies that estimate was favorable and statistically significant at the
p < 0.10 level. To help put the gross Medicare savings in perspective, the total care management fees CMS paid for
attributed Medicare FFS beneficiaries during the four performance years (2013, 2014, 2015, and 2016) were $90.5
million, $76.1 million, $57 million, and $55.9 million, respectively, for a cumulative payment of $278.5 million, after
accounting for total recoupments of about $1 million.
CI = confidence interval; ED = emergency department; LL = lower limit; UL = upper limit.
a
Estimate is statistically significant at the p < 0.10 level
8.4. Discussion
To recap the findings, during the course of the intervention, CPC practices had favorable
findings on service use, with 2 percent less growth than comparison practices in ED visits,
hospitalizations, and office-based primary care visits—but had at best a small effect on total
Medicare expenditures. Although total monthly Medicare FFS expenditures without Medicare’s
CPC care management fees increased by $9 less for beneficiaries in CPC than for beneficiaries
in comparison practices, this did not fully offset the care management fees Medicare paid, which
averaged $15 per month over the course of the initiative. In addition, the Bayesian estimates
235